Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Isle of Wight Clinical Commissioning Group (CCG) is the first to launch an INR self-monitoring service as a pilot to allow some patients to lead a less disrupted life and relieve pressure on warfarin clinics.

The new automated service created by digital health specialist Inhealthcare, transforms how patients on long-term anticoagulation medication warfarin are monitored, empowering them to self-test at home and receive their adjusted warfarin dose via INRstar anticoagulation dosing software. Previously patients on warfarin needed to attend clinic every few weeks for a simple blood test, to check how quickly their blood clots, which is measured using the international normalised ratio (INR).

To read the full article, click here.